IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 253 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.45 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,101,741 | +22.6% | 3,978,385 | +89.7% | 0.01% | +20.0% |
| Q2 2023 | $14,762,990 | +60.1% | 2,097,003 | +38.9% | 0.01% | +66.7% |
| Q1 2023 | $9,221,577 | +87250.4% | 1,509,233 | -8.7% | 0.00% | 0.0% |
| Q4 2022 | $10,557 | -99.9% | 1,652,361 | -0.6% | 0.00% | -50.0% |
| Q3 2022 | $15,927,000 | +15.7% | 1,662,513 | +33.3% | 0.01% | +20.0% |
| Q2 2022 | $13,771,000 | -29.6% | 1,247,360 | +6.2% | 0.01% | -16.7% |
| Q1 2022 | $19,555,000 | +15.8% | 1,174,464 | +32.8% | 0.01% | +20.0% |
| Q4 2021 | $16,886,000 | +107.0% | 884,481 | +167.3% | 0.01% | +66.7% |
| Q3 2021 | $8,158,000 | +79.9% | 330,922 | +89.9% | 0.00% | +200.0% |
| Q2 2021 | $4,536,000 | -24.9% | 174,294 | -8.8% | 0.00% | -50.0% |
| Q1 2021 | $6,043,000 | -6.1% | 191,150 | +37.8% | 0.00% | 0.0% |
| Q4 2020 | $6,437,000 | +99.7% | 138,725 | +41.7% | 0.00% | +100.0% |
| Q3 2020 | $3,223,000 | +75.2% | 97,909 | +46.1% | 0.00% | 0.0% |
| Q2 2020 | $1,840,000 | -86.9% | 67,015 | -85.7% | 0.00% | -85.7% |
| Q1 2020 | $14,077,000 | -34.4% | 470,251 | -39.3% | 0.01% | -12.5% |
| Q4 2019 | $21,452,000 | +44.7% | 774,991 | -4.9% | 0.01% | +33.3% |
| Q3 2019 | $14,824,000 | -25.9% | 814,519 | -0.2% | 0.01% | -25.0% |
| Q2 2019 | $20,007,000 | +489.1% | 815,939 | +128.5% | 0.01% | +700.0% |
| Q1 2019 | $3,396,000 | +7.4% | 357,128 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $3,161,000 | +818.9% | 357,128 | +1067.2% | 0.00% | – |
| Q3 2018 | $344,000 | – | 30,597 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 12,201,261 | $203,150,000 | 4.07% |
| Paradigm Biocapital Advisors LP | 907,428 | $15,109,000 | 4.00% |
| Avoro Capital Advisors LLC | 9,125,000 | $151,931,000 | 2.77% |
| Logos Global Management LP | 1,000,000 | $16,650,000 | 2.16% |
| Avidity Partners Management LP | 6,043,219 | $100,620,000 | 2.10% |
| Orbimed Advisors | 6,633,006 | $110,440,000 | 1.79% |
| Parametrica Management Ltd | 134,679 | $2,240,000 | 1.66% |
| Boxer Capital, LLC | 1,935,133 | $32,220,000 | 1.66% |
| Fairmount Funds Management LLC | 389,588 | $6,487,000 | 1.53% |
| Long Focus Capital Management, LLC | 705,000 | $11,738,000 | 1.51% |